Old Web
English
Sign In
Acemap
>
Paper
>
EMBR-22. RATIONAL DEVELOPMENT OF SYNERGISTIC THERAPIES ALONGSIDE BMI1 INHIBITION FOR GROUP 3 MEDULLOBLASTOMA
EMBR-22. RATIONAL DEVELOPMENT OF SYNERGISTIC THERAPIES ALONGSIDE BMI1 INHIBITION FOR GROUP 3 MEDULLOBLASTOMA
2021
David Bakhshinyan
Ashley A. Adile
Chitra Venugopal
Kevin R. Brown
Katherine Chan
Maleeha Qazi
Chirayu Chokshi
William D. Gwynne
David Tieu
Jason Moffat
Sheila K. Singh
Keywords:
Cancer research
Brain tumor childhood
Medicine
BMI1
Medulloblastoma
recurrence risk
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]